Basilea Pharmaceutica's total assets for Q2 2025 were CHF248.85M, a decrease of -3.46% from the previous quarter. CH:BSLN total liabilities were CHF145.69M for the fiscal quarter, a -17.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.